`

InterVenn Biosciences

Biotechnology Research

Specialities :
Biotech
Artificial intelligence
Proteomics
Glycoproteomics
Epiproteomics

+2

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$201.0M
size-icon Size
51 - 200

Frequently Asked Questions About InterVenn Biosciences

What does Intervenn biosciences do?+

InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist, and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert Aldo Carrascoso on the belief that no one should ever be blindsided by disease. We are focused on decoding the glycoproteome as a rich source of biological insight. Thanks to the use of artificial intelligence (AI), we have pioneered a proprietary technology platform, GlycoVisionTM, to tap into this layer of biology at a clinically meaningful scale. GlycoVision is capable of producing a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and potentially therapeutics. The...

What are Intervenn biosciences's specialties? +

Biotech,artificial intelligence,proteomics,glycoproteomics,epiproteomics,mass spectrometry,and lc-ms

What is Intervenn biosciences's industry? +

Intervenn biosciences operates in the Biotechnology research industry.

What is Intervenn biosciences's revenue? +

Intervenn biosciences's revenue is 11m - 100m

What is Intervenn biosciences's company size? +

Intervenn biosciences has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.